PetMed Express (PETS) Stock: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$1.22
0.04 (3.39%)
▲
5d:
+3.39%
30d:
-21.54%
90d:
-38.07%
BUY
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 48.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 48.7% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $1.22, which is considered slightly low relative to its 30-day fair value range of $1.21 to $1.53. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.4) compared to its historical average (129.1). Remarkably, the market is currently pricing in an annual earnings decline of 48.7% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.15, while resistance sits at $1.30. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: PETS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.40 (+14.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.15, while resistance sits at $1.30. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: PETS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.40 (+14.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.21 -
$1.53
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading below Wall St target ($1.40)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.21 -
$1.53
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$1.30
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.43
Wall Street Target
$1.40
(+14.8%)
Revenue Growth (YoY)
-19.9%
Earnings Growth (YoY)
266.7%
Profit Margin
-17.3%
Valuation Discount vs History
-48.7% cheaper
PE vs Historical
17.4 vs 129.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-48.7%
(market-implied from PE analysis)
1-Year Target
$1.10
(-10%)
2-Year Target
$0.99
(-19%)
3-Year Target
$0.89
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→129)
$6.59
(+440%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.4 to 129.1
Stabilization Target:
$9.04
(+640.7%)
PE Expansion Potential:
+640.7%
Share & Embed Analysis
Last updated: October 24, 2026 7:12 AM ET
Data refreshes hourly during market hours. Next update: 8:12 AM
Data refreshes hourly during market hours. Next update: 8:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
7 analysts |
$5 | 62 BUY |
